HIGHLIGHTS
- who: Ziyao Lu and collaborators from the Fujian Provincial Key Laboratory of Tumor Biotherapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China have published the Article: Dual-Activated Nano-Prodrug for Chemo-Photodynamic Combination Therapy of Breast Cancer, in the Journal: (JOURNAL) of 20/Oct/2022
- what: The authors designed a prodrug that combines passive targeting and stepwise activation.
- how: The results indicated that both BTC and BCC did not effectively generate singlet oxygen. Transmission electron microscopy (TEM) results showed that the BTC NPs and BCC NPs had uniform . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.